Assertio Therapeutics

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$9,933
$13,542
$49,459
$29,222
Gross Profit
1,382
4,437
30,175
9,277
EBITDA
-12,630
-3,310
18,532
1,233
EBIT
-18,470
-9,149
12,902
-8,035
Net Income
-18,856
-11,928
11,445
-16,352
Net Change In Cash
9,933
13,542
49,459
29,222
Free Cash Flow
8,563
-29,968
-4,767
19,091
Cash
33,713
10,229
38,500
47,086
Basic Shares
6,434
6,420
7,100
6,398

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$118,713
$124,961
$152,069
$156,234
Gross Profit
53,325
85,734
125,049
137,486
EBITDA
12,782
5,146
53,170
90,170
EBIT
-17,223
-20,683
24,941
56,774
Net Income
-30,375
-21,581
-331,942
109,625
Net Change In Cash
118,713
124,961
152,069
156,234
Free Cash Flow
-28,182
26,408
48,976
78,324
Cash
10,229
50,588
73,441
64,941
Basic Shares
6,403
6,351
4,735
3,644

Earnings Calls

QuarterEPS
2026-03-31
-$2.93
2025-12-31
-$1.06
2025-09-30
$0.18
2025-06-30
-$0.17